In association with the increased inflammatory cytokines TNF-α and IL-6, the NAFLD group showed significant increases in the serum leptin levels (p < 0.001) and decreased adiponectin production (p < 0.0001) in comparison to the control group (Figures 5(c) and 5(d)). This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.